Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?

Reviewed 10 sourcesPublished by PepVault

Dizziness hit 8% on Wegovy vs 4% on placebo, 4-5% on Zepbound vs 2%. How to tell dehydration, falling blood pressure and low blood sugar apart, and what helps.

Man in a grey tee rests eyes closed on a white sofa under a blue throw, water glass and monstera beside him
Last reviewed
Sources
10
Questions
6
Compounds
2

The short answer

Most often it is fluid or blood pressure; blood sugar matters mainly with insulin or a sulfonylurea. On the labels, dizziness hit 8% on Wegovy against 4% on placebo, and 4 to 5% on Zepbound against 2%. Vomiting, diarrhoea or drinking little drains fluid, and weight loss lowers blood pressure, most on blood-pressure pills. Sitting down and fluids settle most spells; any medicine change is your prescriber's.

Every number checked at its primary source · · 10 sources · How we research

Evidence: FDA prescribing information for Wegovy, Zepbound, Ozempic and Mounjaro (DailyMed, versions current in November 2026) with their placebo-controlled trial data; a pooled analysis of the STEP 1-3 trials (2022), a 24-hour blood-pressure substudy of SURMOUNT-1 (2024) and an individual-patient meta-analysis of three STEP trials (2024), all funded by the makers or using their data; a 2024 clinical review; NHLBI and NIDDK patient guidance on low blood pressure and low blood sugar.

Man in a grey tee rests eyes closed on a white sofa under a blue throw, water glass and monstera beside him

How common is dizziness on Wegovy, Zepbound, Ozempic and Mounjaro?

Between 4% and 8% of people on the weight-loss doses, roughly twice the rate on placebo (a dummy injection). Here is each label's own count, as of November 2026. The last column is the labels' line for low blood pressure (they group a low reading, a drop on standing and "blood pressure decreased" together) and for fainting:

Drug and trialsDizziness on placeboDizziness on the drugLow blood pressure and fainting
Wegovy 2.4 mg, adults, three weight trials up to 68 weeks4%8%1Low blood pressure 1.3% vs 0.4%; fainting 0.8% vs 0.2%1
Wegovy 7.2 mg, adults, two 72-week trials (dizziness on standing counted in)1%6%, against 5% on 2.4 mg1Not given separately1
Wegovy 2.4 mg, teens 12 to 17, 68 weeks3%8%1Low blood pressure 2.3% vs 0%; fainting not given1
Zepbound, adults, two 72-week trials2%4% at 5 mg, 5% at 10 mg, 4% at 15 mg2Low blood pressure 1.6% vs 0.1%2
Ozempic, type 2 diabetes trialsNot givenListed among effects above 0.4%, with no rate3Not listed3
Mounjaro, type 2 diabetes trialsNot listedNot listed in the trial tables4Not listed4

The Wegovy pill's trial found side effects of the same kinds and rates as the 2.4 mg injection1. Every label warns that rates from different trials cannot be compared directly, so read each row against its own placebo12. Ozempic and Mounjaro are diabetes drugs at lower doses, and both labels name dizziness or light-headedness as a sign of low blood sugar rather than giving a trial rate34.

In PepVault, a dizzy spell goes in the side-effect log under the compound you take, with its date, a severity from minimal to very severe and a note for what you had eaten and drunk. Log it in PepVault

A smiling woman in a blue top leaning on her kitchen counter with her phone and a notebook

PepVault for iPhone

Keep your protocol in PepVault

In PepVault, a dizzy spell goes in the side-effect log under the compound you take, with its date, a severity from minimal to very severe and a note for what you had eaten and drunk.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Can a GLP-1 make you dizzy through dehydration?

Yes, and it is the cause the labels name most. Dehydration means the body has lost more water than it took in, so there is less fluid in the blood vessels and less pressure behind each heartbeat. All four labels say it plainly: diarrhoea, nausea and vomiting may cause a loss of fluids, and drinking fluids lowers the chance of it1234. On Wegovy 2.4 mg, 44% had nausea against 16% on placebo, 24% vomiting against 6%, and 30% diarrhoea against 16%1. A smaller appetite also means less food, and food carries a good part of a day's water.

The labels tie the low-pressure reactions to the same fluid loss. Wegovy's says some were related to stomach side effects and volume loss1; Zepbound's says low blood pressure also came with stomach side effects and dehydration2. When the loss runs long it can strain the kidneys, which our guide to GLP-1s and the kidneys covers12.

Does a GLP-1 lower your blood pressure enough to make you dizzy?

It lowers it for most people, and for a few that is enough to feel. In Wegovy's main weight trial, the top number (systolic pressure, the push while the heart beats) fell 6.2 mmHg in 68 weeks, against 1.1 on placebo1. In Zepbound's it fell 6.6 to 7.7 mmHg in 72 weeks, against 1.02. A 24-hour monitor in the Zepbound trial (494 people with full readings) found falls of 7.4 to 10.6 mmHg beyond placebo by week 36, day and night, and the weight lost accounted for about 70% of the fall6.

The risk sits with blood-pressure medicines. A dose that was right at your old weight can be too strong at the new one. On Zepbound, low blood pressure came in 2.2% of people taking a blood-pressure medicine and 1.2% of those who were not2; the Wegovy label reports the same tilt1. Pooling three Wegovy trials, 7.1% had a blood-pressure medicine cut back or stopped, against 3.5% on placebo; the authors put the difference at about half of one standard dose7. Whether yours changes is your prescriber's decision.

The dizziness itself usually comes on standing. Orthostatic hypotension is the name for a drop of at least 20 mmHg in the top number, or 10 in the bottom one, within three minutes of standing up8. Wegovy's 7.2 mg trials counted "dizziness postural", the dizzy spell on standing, in their dizziness line1.

Is dizziness on a GLP-1 a sign of low blood sugar?

It can be, mainly with diabetes medicines. All four labels list dizziness or light-headedness first among the signs of low blood sugar1234. Without diabetes, lows are rare: in Zepbound's trial of adults without diabetes, a reading under 54 mg/dL came in 0.3% against none on placebo2. With type 2 diabetes they rise, and most with insulin or a sulfonylurea (glipizide, glimepiride, glyburide: older diabetes pills). On Wegovy, 6.2% had a reading under 54 mg/dL against 2.5% on placebo1. On Zepbound it was 4.2% against 1.3%, and 10.3% of those also on a sulfonylurea against 2.1% of those not on one2.

A finger-stick meter or a glucose sensor settles it: a normal reading during a spell points away from sugar. Our guide to low blood sugar on a GLP-1 covers the rates in full, why the risk stays low without diabetes, and the 15-to-20-gram rule for treating a low.

When does dizziness start on a GLP-1, and which cause is it?

No label gives the week dizziness starts12. The trial tables do show when each cause peaks, and that is the most useful clue. In the three main Wegovy trials, nausea, vomiting and diarrhoea peaked at about week 20, just after the climb to 2.4 mg ends at week 16, and first-time stomach effects levelled off after it5. The Zepbound label puts most of them during the dose climb too2. Blood pressure falls with the weight, so it builds over months6. With insulin or a sulfonylurea, the Zepbound label asks prescribers to consider lowering those doses when the drug starts, to lower the chance of a low2.

CauseWhat points to itWhen it tends to comeWhat settles it
DehydrationA day of vomiting, diarrhoea or drinking little12The first weeks and the days after each dose step-up25Fluids, and the stomach effects settling12
Blood pressure fallingDizzy mostly on standing up; on a blood-pressure medicineBuilds with the weight lost, over months6A home cuff reading, sitting then standing8
Low blood sugarShaky, sweaty or hungry too; on insulin or a sulfonylurea2From the start, with those medicines2A meter reading under 70 mg/dL10

Commonly reported: light-headedness on standing up or getting out of bed, on a day of eating or drinking very little, most often in the first weeks or right after a step-up, easing with water and food. On our reports pages it is a rare complaint: 1 of 41 semaglutide write-ups and 1 of 77 tirzepatide write-ups name dizziness or low blood pressure.

What helps when you feel dizzy on a GLP-1?

  1. Sit or lie down as soon as the room starts to move; sitting often settles the symptoms of low blood pressure9.
  2. Drink. The labels' own advice is fluids to lower the chance of dehydration12; in small studies of people with orthostatic hypotension from nerve disorders (not GLP-1 users), half a litre of water eased the drop on standing at 30 minutes8.
  3. If you use insulin or a sulfonylurea, check your blood sugar; under 70 mg/dL is a low, and our low blood sugar guide has the steps10.
  4. Stand up in stages. If it starts again, cross your legs and tense your thigh and calf muscles, or squat; these moves push blood back up from the legs8.
  5. On a day of nausea, eat small amounts and keep sipping; tell your prescriber if vomiting or diarrhoea does not stop12.
  6. If you take a blood-pressure medicine, take a few home readings, sitting and standing, and bring them to your prescriber; any change to the dose is theirs to make27.

PepVault's weight chart shows how far and how fast your weight has come down, the number to bring beside your blood-pressure readings when you and your prescriber look at your medicines. Track your weight in PepVault

When to get help Fainting, or dizziness with cold and sweaty skin, fast breathing and a weak, racing pulse, or with swelling of the face or throat and trouble breathing, needs emergency care right away19.

Track it in the app

Sources

  1. WEGOVY (semaglutide) injection and tablets prescribing information, Novo Nordisk, DailyMed (SPL version 19), June 2026 dailymed.nlm.nih.gov
  2. ZEPBOUND (tirzepatide) injection prescribing information, Eli Lilly, DailyMed (SPL version 40), September 2026 dailymed.nlm.nih.gov
  3. OZEMPIC (semaglutide) injection prescribing information, Novo Nordisk, DailyMed (SPL version 20), June 2026 dailymed.nlm.nih.gov
  4. MOUNJARO (tirzepatide) injection prescribing information, Eli Lilly, DailyMed (SPL version 40), September 2026 dailymed.nlm.nih.gov
  5. Wharton S, Calanna S, Davies M, Dicker D, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022;24(1):94-105. PubMed 34514682
  6. de Lemos JA, Linetzky B, le Roux CW, Laffin LJ, et al. Tirzepatide reduces 24-hour ambulatory blood pressure in adults with body mass index ≥27 kg/m2: SURMOUNT-1 ambulatory blood pressure monitoring substudy. Hypertension. 2024;81(4):e41-e43. PubMed 38314555
  7. Kennedy C, Hayes P, Cicero AFG, Dobner S, et al. Semaglutide and blood pressure: an individual patient data meta-analysis. Eur Heart J. 2024;45(38):4124-4134. PubMed 39217502
  8. Kulkarni S, Jenkins D, Dhar A, Mir F, et al. Treating lows: management of orthostatic hypotension. J Cardiovasc Pharmacol. 2024;84(3):303-315. PubMed 39027973
  9. National Heart, Lung, and Blood Institute (NHLBI). Low blood pressure. Last updated March 24, 2022. nhlbi.nih.gov
  10. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Low blood glucose (hypoglycemia). Last reviewed July 2021. niddk.nih.gov

Newsletter · Weekly

The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

We’ll email you a link to confirm. Your address is used for the briefing only. Privacy

PepVault for iPhone

Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo